81 related articles for article (PubMed ID: 38762674)
1. Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
Mizukami Y; Kono K; Daigo Y; Takano A; Tsunoda T; Kawaguchi Y; Nakamura Y; Fujii H
Cancer Sci; 2008 Jul; 99(7):1448-54. PubMed ID: 18452554
[TBL] [Abstract][Full Text] [Related]
2. Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer.
Ko KP; Zhang S; Huang Y; Kim B; Zou G; Jun S; Zhang J; Martin C; Dunbar KJ; Efe G; Rustgi AK; Zhang H; Nakagawa H; Park JI
bioRxiv; 2023 Feb; ():. PubMed ID: 36824935
[TBL] [Abstract][Full Text] [Related]
3. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
List AF; Spier CM; Miller TP; Grogan TM
Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL.
Xu-Monette ZY; Li Y; Snyder T; Yu T; Lu T; Tzankov A; Visco C; Bhagat G; Qian W; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; Hagemeister FB; Wang Y; Go H; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; Fan X; van Krieken JH; Piris MA; Winter JN; Au Q; Kirsch I; Zhang M; Shaughnessy J; Xu B; Young KH
Clin Cancer Res; 2023 Dec; 29(23):4808-4821. PubMed ID: 37728879
[TBL] [Abstract][Full Text] [Related]
5. Digital assessment of tertiary lymphoid structures and therapeutic responses in gastric cancer: A multi-centric retrospective study.
Chen Y; Sun Z; Yin J; Ahmad MU; Zhou Z; Feng W; Yang F; Zhou K; Xie J; Bie C; Chen H; Jiang Y
Int J Surg; 2024 Jun; ():. PubMed ID: 38884256
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng KW; Boumelha J; Enfield KSS; Almagro J; Cha H; Pich O; Karasaki T; Moore DA; Salgado R; Sivakumar M; Young G; Molina-Arcas M; de Carné Trécesson S; Anastasiou P; Fendler A; Au L; Shepherd STC; Martínez-Ruiz C; Puttick C; Black JRM; Watkins TBK; Kim H; Shim S; Faulkner N; Attig J; Veeriah S; Magno N; Ward S; Frankell AM; Al Bakir M; Lim EL; Hill MS; Wilson GA; Cook DE; Birkbak NJ; Behrens A; Yousaf N; Popat S; Hackshaw A; ; ; Hiley CT; Litchfield K; McGranahan N; Jamal-Hanjani M; Larkin J; Lee SH; Turajlic S; Swanton C; Downward J; Kassiotis G
Nature; 2023 Apr; 616(7957):563-573. PubMed ID: 37046094
[TBL] [Abstract][Full Text] [Related]
7. Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study.
Lei JX; Wang R; Hu C; Lou X; Lv MY; Li C; Gai B; Wu XJ; Dou R; Cai D; Gao F
Int J Surg; 2024 Jun; ():. PubMed ID: 38833363
[TBL] [Abstract][Full Text] [Related]
8. The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma.
Wang Z; Zhao Y; Wo Y; Peng Y; Hu W; Wu Z; Liu P; Shang Y; Liu C; Chen X; Huang K; Chen Y; Hong H; Li F; Sun Y
Cancer Lett; 2024 Jul; 593():216951. PubMed ID: 38734159
[TBL] [Abstract][Full Text] [Related]
9. Tumor niche network-defined subtypes predict immunotherapy response of esophageal squamous cell cancer.
Ko KP; Zhang S; Huang Y; Kim B; Zou G; Jun S; Zhang J; Zhao Y; Martin C; Dunbar KJ; Efe G; Rustgi AK; Nakagawa H; Zhang H; Liu Z; Park JI
iScience; 2024 May; 27(5):109795. PubMed ID: 38741711
[TBL] [Abstract][Full Text] [Related]
10. A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.
Kinget L; Naulaerts S; Govaerts J; Vanmeerbeek I; Sprooten J; Laureano RS; Dubroja N; Shankar G; Bosisio FM; Roussel E; Verbiest A; Finotello F; Ausserhofer M; Lambrechts D; Boeckx B; Wozniak A; Boon L; Kerkhofs J; Zucman-Rossi J; Albersen M; Baldewijns M; Beuselinck B; Garg AD
Nat Med; 2024 Jun; 30(6):1667-1679. PubMed ID: 38773341
[TBL] [Abstract][Full Text] [Related]
11. The tumor-driven antibody-mediated immune response in cancer.
Paparoditis P; Shulman Z
Curr Opin Immunol; 2024 Jun; ():102431. PubMed ID: 38866666
[TBL] [Abstract][Full Text] [Related]
12. HLA-A
Zhang D; Jiang D; Jiang L; Ma J; Wang X; Xu X; Chen Z; Jiang M; Ye W; Wang J; Meng W; Qiu W; Hou Y; Huang J; Jiao Y; Liu Y; Liu Z
Br J Cancer; 2024 May; ():. PubMed ID: 38762674
[TBL] [Abstract][Full Text] [Related]
13. Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response.
Chen Z; Wang X; Jin Z; Li B; Jiang D; Wang Y; Jiang M; Zhang D; Yuan P; Zhao Y; Feng F; Lin Y; Jiang L; Wang C; Meng W; Ye W; Wang J; Qiu W; Liu H; Huang D; Hou Y; Wang X; Jiao Y; Ying J; Liu Z; Liu Y
NPJ Precis Oncol; 2024 Mar; 8(1):73. PubMed ID: 38519580
[TBL] [Abstract][Full Text] [Related]
14. A high interferon gamma signature of CD8
Li S; Li K; Tian F; Li H; Xia Q; Li T; Dong B; Li D; Yu J; Zhang J; Wang L; Zhang C; Xu S; Zhao Y; Liu Y
Front Immunol; 2022; 13():1056144. PubMed ID: 36685525
[TBL] [Abstract][Full Text] [Related]
15. CD8
Prokhnevska N; Cardenas MA; Valanparambil RM; Sobierajska E; Barwick BG; Jansen C; Reyes Moon A; Gregorova P; delBalzo L; Greenwald R; Bilen MA; Alemozaffar M; Joshi S; Cimmino C; Larsen C; Master V; Sanda M; Kissick H
Immunity; 2023 Jan; 56(1):107-124.e5. PubMed ID: 36580918
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
Liu Z; Meng X; Tang X; Zou W; He Y
Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
[TBL] [Abstract][Full Text] [Related]
17. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.
Meylan M; Petitprez F; Becht E; Bougoüin A; Pupier G; Calvez A; Giglioli I; Verkarre V; Lacroix G; Verneau J; Sun CM; Laurent-Puig P; Vano YA; Elaïdi R; Méjean A; Sanchez-Salas R; Barret E; Cathelineau X; Oudard S; Reynaud CA; de Reyniès A; Sautès-Fridman C; Fridman WH
Immunity; 2022 Mar; 55(3):527-541.e5. PubMed ID: 35231421
[TBL] [Abstract][Full Text] [Related]
18. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer.
Liu B; Hu X; Feng K; Gao R; Xue Z; Zhang S; Zhang Y; Corse E; Hu Y; Han W; Zhang Z
Nat Cancer; 2022 Jan; 3(1):108-121. PubMed ID: 35121991
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
